GoFintech Quantum Partners With QureGenAI Biotech on Quantum Drug Discovery; Shares Gain 3%
MT Newswires Live
Yesterday
GoFintech Quantum Innovation (HKG:0290) signed a non-binding strategic cooperation memorandum with QureGenAI (Suzhou) Biotechnology to collaborate on quantum computing and AI-driven drug discovery, according to a May 8 Hong Kong bourse filing.
Shares of the securities brokerage firm were up over 3% in Monday morning trade.
The companies plan to cooperate through a milestone-based licensing model covering quantum computing drug discovery platforms, a quantum frontier technology investment fund, and a quantum computing center in Hong Kong.
The companies aim to finalize a definitive agreement within 90 days of signing the memorandum.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.